Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dooley

Showing results (171-180 of 263) with videos related to

Pageof 27
Sort By:
Academic Pediatrics|October 28, 2023
Associations Between Adverse Childhood Experiences and Early Adolescent Physical Activity in the United StatesAbubakr A A Al-Shoaibi, Puja Iyra, Julia H Raney, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2016
Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunitiesS E McAnaw, A C Hesseling, J A Seddon, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2017
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infantsHelen McIlleron, Paolo Denti, Silvia Cohn, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampinKelly E Dooley, Anne F Luetkemeyer, Jeong-Gun Park, et al.
BMC Medicine|March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 19, 2026
Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Wuyang Zhang, Erin E Dooley, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenR M Savic, R Ruslami, J E Hibma, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 28, 2025
Association of multimorbidity trajectories from early adulthood through middle age with middle-age physical functionC Barrett Bowling, Richard Sloane, Richard A Faldowski, et al.
Annals of Epidemiology|December 5, 2024
Gender diversity and daily steps: Findings from the Adolescent Brain Cognitive Development StudyJason M Nagata, Shirley Sui, Angela E Kim, et al.
American Journal of Preventive Cardiology|November 7, 2024
Associations of adverse childhood experiences with blood pressure among early adolescents in the United StatesAbubakr A A Al-Shoaibi, Christopher M Lee, Julia H Raney, et al.
Pageof 27

Showing results (171-180 of 263) with videos related to

Sort By:
Pageof 27
Academic Pediatrics|October 28, 2023
Associations Between Adverse Childhood Experiences and Early Adolescent Physical Activity in the United StatesAbubakr A A Al-Shoaibi, Puja Iyra, Julia H Raney, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 14, 2016
Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunitiesS E McAnaw, A C Hesseling, J A Seddon, et al.
The Journal of Antimicrobial Chemotherapy|April 19, 2017
Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infantsHelen McIlleron, Paolo Denti, Silvia Cohn, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampinKelly E Dooley, Anne F Luetkemeyer, Jeong-Gun Park, et al.
BMC Medicine|March 24, 2016
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)Patrick P J Phillips, Kelly E Dooley, Stephen H Gillespie, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 19, 2026
Accelerometer-derived daily steps, cognition, and cognitive impairment in U.S. community-dwelling older adults: The Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Wuyang Zhang, Erin E Dooley, et al.
Clinical Pharmacology and Therapeutics|August 12, 2015
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for childrenR M Savic, R Ruslami, J E Hibma, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 28, 2025
Association of multimorbidity trajectories from early adulthood through middle age with middle-age physical functionC Barrett Bowling, Richard Sloane, Richard A Faldowski, et al.
Annals of Epidemiology|December 5, 2024
Gender diversity and daily steps: Findings from the Adolescent Brain Cognitive Development StudyJason M Nagata, Shirley Sui, Angela E Kim, et al.
American Journal of Preventive Cardiology|November 7, 2024
Associations of adverse childhood experiences with blood pressure among early adolescents in the United StatesAbubakr A A Al-Shoaibi, Christopher M Lee, Julia H Raney, et al.
Pageof 27